Atlas Trials

Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease

Clinical trial NCT05348096 · UNKNOWN

Trial details

NCT number
NCT05348096
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Graft-versus-host-disease
Start date
2022-04-01
Primary completion
2023-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.